Published in Gen Hosp Psychiatry on April 18, 2012
Rare and very rare adverse effects of clozapine. Neuropsychiatr Dis Treat (2015) 0.88
Nomenclature of drug-induced pityriasis rosea-like rashes. Neuropsychiatr Dis Treat (2015) 0.75
Acid-base interpretation can be the predictor of outcome among patients with acute organophosphate poisoning before hospitalization. Am J Emerg Med (2008) 2.19
Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol (2003) 1.84
Association between pulse pressure and peritoneal transport status in patients undergoing peritoneal dialysis. Perit Dial Int (2010) 1.45
Venlafaxine-induced excessive yawning. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.43
History of the discovery and clinical introduction of chlorpromazine. Ann Clin Psychiatry (2006) 1.31
Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study. J Clin Psychiatry (2013) 1.12
Cabergoline-induced psychotic exacerbation in schizophrenic patients. Gen Hosp Psychiatry (2008) 1.10
Long-term psychological outcome of 1999 Taiwan earthquake survivors: a survey of a high-risk sample with property damage. Compr Psychiatry (2007) 1.07
Polyunsaturated fatty acid deficit in patients with bipolar mania. Eur Neuropsychopharmacol (2003) 1.05
Immunologic variables in acute mania of bipolar disorder. J Neuroimmunol (2004) 1.02
ABCB1 gene polymorphisms are associated with the severity of major depressive disorder and its response to escitalopram treatment. Pharmacogenet Genomics (2011) 1.00
Hypertensive disorders in pregnancy and subsequent diabetes mellitus: a retrospective cohort study. Am J Med (2012) 0.99
Surgical adverse outcomes in patients with schizophrenia: a population-based study. Ann Surg (2013) 0.98
Uremic pruritus, cytokines, and polymethylmethacrylate artificial kidney. Artif Organs (2008) 0.97
Posttraumatic stress disorder among professional and non-professional rescuers involved in an earthquake in Taiwan. Psychiatry Res (2004) 0.96
Implication of serum concentration monitoring in patients with lithium intoxication. Psychiatry Clin Neurosci (2004) 0.95
Serotonin syndrome induced by low-dose venlafaxine. Ann Pharmacother (2003) 0.94
Subclinical peripheral artery disease in patients undergoing peritoneal dialysis: risk factors and outcome. Perit Dial Int (2009) 0.94
Sleep-related eating disorder induced by risperidone. J Clin Psychiatry (2004) 0.94
Waist-to-height ratio is the best index of obesity in association with chronic kidney disease. Nutrition (2007) 0.92
Psychiatric disorders after epilepsy diagnosis: a population-based retrospective cohort study. PLoS One (2013) 0.91
Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. Alcohol Alcohol (2008) 0.91
The validation study and application of stratum-specific likelihood ratios in the Chinese version of SPAN. Compr Psychiatry (2003) 0.90
Olanzapine-induced QTc prolongation in a patient with Wolff-Parkinson-White syndrome. Schizophr Res (2004) 0.89
Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response. Pharmacogenomics (2010) 0.88
Association between pulse pressure and 30-month all-cause mortality in peritoneal dialysis patients. Am J Hypertens (2008) 0.87
Warfarin-induced calciphylaxis in a chronic hypercalcemic patient. Indian J Dermatol Venereol Leprol (2012) 0.87
Modulation of the development of human monocyte-derived dendritic cells by lithium chloride. J Cell Physiol (2011) 0.85
Mortality in hepatitis C-positive patients treated with peritoneal dialysis. Perit Dial Int (2008) 0.85
Prevalence and identification of alcohol use disorders among severe mental illness inpatients in Taiwan. Psychiatry Clin Neurosci (2009) 0.84
Association between betelnut chewing and chronic kidney disease in adults. J Occup Environ Med (2007) 0.84
Omega-3 fatty acids for depression in pregnancy. Am J Psychiatry (2003) 0.84
Somnambulism secondary to olanzapine treatment in one patient with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.84
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine. Pharmacogenomics (2010) 0.84
Bacteremia in hemodialysis and peritoneal dialysis patients. Intern Med (2012) 0.83
Metformin for metabolic dysregulation in schizophrenic patients treated with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.83
Association between frailty and subclinical peripheral vascular disease in a community-dwelling geriatric population: Taichung Community Health Study for Elders. Geriatr Gerontol Int (2014) 0.83
ECT generalized seizure drives heart rate above treadmill stress test maximum. J ECT (2007) 0.83
Screening postpartum depression with the Taiwanese version of the Edinburgh Postnatal Depression scale. Compr Psychiatry (2005) 0.83
Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.83
The time-dependent change of insulin secretion in schizophrenic patients treated with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.83
Health-seeking behavior, alternative medicine, and quality of life in Taiwanese panic disorder patients. Int J Psychiatry Clin Pract (2012) 0.82
Pharmacokinetics of olanzapine in Chinese male schizophrenic patients with various smoking behaviors. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.82
Worsening psychosis after adding aripiprazole to clozapine. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.81
Paliperidone-induced mania-like symptoms: a case report. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.81
Reduced production of interferon-gamma but not interleukin-10 in bipolar mania and subsequent remission. J Affect Disord (2002) 0.81
The early effect of olanzapine and risperidone on insulin secretion in atypical-naïve schizophrenic patients. J Clin Psychopharmacol (2006) 0.81
Gender differences in the effects of peroxisome proliferator-activated receptor γ2 gene polymorphisms on metabolic adversity in patients with schizophrenia or schizoaffective disorder. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.81
Trends in scientific literature on atypical antipsychotics in South Korea: a bibliometric study. Psychiatry Investig (2013) 0.81
Use of low-dose topiramate in substance use disorder and bodyweight control. Psychiatry Clin Neurosci (2007) 0.81
A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients. Ren Fail (2006) 0.80
Peripheral arterial disease and clinical risks in Taiwanese hemodialysis patients. Angiology (2009) 0.79
Associations between n-3 PUFA concentrations and cognitive function after recovery from late-life depression. Am J Clin Nutr (2012) 0.79
Age, gender, depression, and sexual dysfunction in Taiwan. J Sex Med (2009) 0.79
Relation of ankle-brachial index to the rate of decline of residual renal function in peritoneal dialysis patients. Nephrology (Carlton) (2011) 0.79
Metoclopramide-induced supersensitivity psychosis. Ann Pharmacother (2002) 0.79
Taiwan consensus of pharmacological treatment for bipolar disorder. J Chin Med Assoc (2013) 0.79
The prevalence of gallbladder stones is higher among patients with chronic kidney disease in Taiwan. Medicine (Baltimore) (2009) 0.79
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions. Pharmacogenomics (2013) 0.78
Validation of apathy evaluation scale and assessment of severity of apathy in Alzheimer's disease. Psychiatry Clin Neurosci (2012) 0.78
Ovarian cancer and antidepressants. Psychooncology (2014) 0.78
A pilot cross-over design study on QTc interval prolongation associated with sulpiride and haloperidol. Schizophr Res (2003) 0.78
Associations of polyunsaturated fatty acids with residual depression or anxiety in older people with major depression. J Affect Disord (2011) 0.78
Risk factors associated with end-stage renal disease (ESRD) in patients with atherosclerotic renal artery stenosis: a nationwide population-based analysis. Medicine (Baltimore) (2015) 0.78
Dose-dependent alternations in the pharmacokinetics of olanzapine during coadministration of fluvoxamine in patients with schizophrenia. J Clin Pharmacol (2004) 0.78
Aripiprazole resolves symptomatic hyperprolactinemia in a male schizophrenic patient. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.77
Double Filtration Plasma Apheresis Shortens Hospital Admission Duration of Patients With Severe Hypertriglyceridemia-Associated Acute Pancreatitis. Pancreas (2016) 0.77
Increased risk of Parkinson's disease in patients with end-stage renal disease: a retrospective cohort study. Neuroepidemiology (2014) 0.77
Association between mean arterial pressure and mortality in chronic hemodialysis patients. Kidney Blood Press Res (2009) 0.77
The Relationships of Obesity-Related Genetic Variants With Metabolic Profiles and Response to Metformin in Clozapine-Treated Patients With Schizophrenia. J Clin Psychopharmacol (2015) 0.76
The relationship between serum uric acid concentration and metabolic syndrome in patients with schizophrenia or schizoaffective disorder. J Clin Psychopharmacol (2012) 0.76
The association between ankle-brachial index and quality of life in chronic hemodialysis patients. Angiology (2010) 0.76
Comparison of hepatitis B surface antibody decay rates after vaccination between hemodialysis and peritoneal dialysis patients. Vaccine (2011) 0.76
Mapping the scientific research on atypical antipsychotic drugs in Spain: a bibliometric assessment. Actas Esp Psiquiatr (2013) 0.76
Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients. J Clin Psychopharmacol (2007) 0.76
Application of the Cockcroft-Gault method to estimate lithium dosage requirement. Psychiatry Clin Neurosci (2007) 0.76
Weight gain and ghrelin level after olanzapine monotherapy. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.76
Reduction of pro-inflammatory cytokines through hemodiafiltration. Ren Fail (2008) 0.75
Fluvoxamine-clozapine interaction: time-dependent? J Clin Psychopharmacol (2002) 0.75
The relationships of sleep apnea, hypertension, and resistant hypertension on chronic kidney disease. Medicine (Baltimore) (2016) 0.75
New-onset Atrial Fibrillation is Associated With Polycystic Kidney Disease: A Nationwide Population-based Cohort Study. Medicine (Baltimore) (2016) 0.75
Comment: risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine. Ann Pharmacother (2002) 0.75
Images in a patient on chronic haemodialysis with low back pain and Staphylococcus septicaemia. BMJ Case Rep (2009) 0.75
Comments on article by Albers et al: "Low-dose fluvoxamine as an adjunct to reduce olanzapine therapeutic dose requirements: a prospective dose-adjusted drug interaction strategy". J Clin Psychopharmacol (2005) 0.75
Prolongation of QTc interval and antipsychotics. Am J Psychiatry (2002) 0.75
A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.75
Heavy smoking, reduced olanzapine levels, and treatment effects: a case report. Ther Drug Monit (2004) 0.75
Estimation of lithium dose requirement by body weight. Bipolar Disord (2002) 0.75
A social skills training program for preschool children with attention-deficit/hyperactivity disorder. Chang Gung Med J (2004) 0.75